Lymphocyte Response in Subjects with Chronic Pulmonary Disease Colonized by Pneumocystis jirovecii

Journal of Eukaryotic Microbiology

Volumn 50, Issue SUPPL., 2003, Pages 672-673

  Varela, Jose M ^a   Respaldiza, Nieves ^a   Sánchez, Berta ^a   De La Horra, Carmen ^a   Montes Cano, Marco ^a   Rincón, Manuel ^a   Dapena, Javier ^a   González Becerra, Concepción ^a   Medrano, Francisco J ^a   Calderón, Enrique ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE;

BRONCHUS DISEASE; CHRONIC DISEASE; COMPARATIVE STUDY; CONFERENCE PAPER; CYSTIC FIBROSIS; GENETICS; HETEROZYGOTE; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG DISEASE; LYMPHOCYTE; LYMPHOCYTE COUNT; MICROBIOLOGY; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; SERODIAGNOSIS;

BRONCHIAL DISEASES; CARRIER STATE; CHRONIC DISEASE; CYSTIC FIBROSIS; HIV SERONEGATIVITY; HUMANS; LUNG DISEASES; LYMPHOCYTE COUNT; LYMPHOCYTES; PNEUMOCYSTIS JIROVECI; PNEUMONIA, PNEUMOCYSTIS; POLYMERASE CHAIN REACTION;

BRONCHUS; PNEUMOCYSTIS; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS JIROVECII;

EID: 9144223004     PISSN: 10665234     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1550-7408.2003.tb00680.x     Document Type: Conference Paper

References (20)

1. Stringer, J.R., Beard, C.B., Miller, R.F., & Wakefield, A.E. 2002. A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg. Infect. Dis., 8:891-896.
2. Calderón-Sandubete, E.J., Varela-Aguilar, J.M., Medrano-Ortega, F.J., Nieto-Guerrero, V., Respaldiza-Salas, N., de la Horra-Padilla, C. & Dei-Cas E. 2002. Historical perspective on Pneumocystis carinii infection. Protist, 153:303-310.
3. Kaplan, J.E., Jones, J.L. & Dykewicz, CA. 2000. Protists as opportunistic pathogens: Public health impact in the 1990s and beyond. J. Eukaryot. Microbiol., 47:15-20.
4. Cardenal, R., Medrano, F.J., Varela, J.M., Ordoñez, A., Regordán, C., Rincón, M., Martinez, A. & Calderón E. 2001. Pneumocystis carinii pneumonia in heart transplant recipients. Eur. J. Cardiothorac. Surg., 20:799-802.
5. Ognibene, F.P., Shelhamer, J.H., Hoffman, G.S., Kerr, G.S., Reda, D., Fauci, A.S., & Leavitt, R.Y. 1995. Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. Am. J. Respir. Crit. Care. Med., 151:795-799.
6. Varthalitis, I., Aoun, M., Daneau, D. & Meunier, E. 1993. Pneumocystis carinii pneumonia in patients with cancer, an increasing incidence. Cancer, 71:481-485.
7. Jacobs, J.L., Libby, D.M., Winters, R.A., Gelmont, D.M., Fried, E.D., Hartman, B.J. & Laurence, J. 1991. A cluster of Pneumocystis carinii pneumonia in adults without predisposing illnesses. N. Engl. J. Med., 324:246-250.
8. Cano, S., Capote, F., Pereira, A., Calderón, E. & Castillo, J. 1993. Pneumocystis carinii pneumonia in patients without predisposing illnesses. Acute episode and follow-up of five cases. Chest, 104:376-381.
9. Calderón, E., Medrano, F.J., Cano, S. & Varela, J.M. 1996. Neumonía por Pneumocystis carinii en toxicómana sin evidencia de infección VIII. Enf. Infec. Microbiol. Clin., 14:505.
10. Calderón, E.J., Regordan, C., Medrano, F.J., Ollero, M. & Varela, J.M. 1996. Pneumocystis carinii infection in patients with chronic bronchial disease. Lancet, 347:977.
11. Sing, A., Roggenkamp, A., Autenrieth, I.B. & Heesemann, J. 1999. Pneumocystis carinii carriage in immunocompetent patients with primary pulmonary disorders as detected by single o nested PCR. J. Clin. Microbiol., 37:3409-3410.
12. Mazur, H., Frederick, P. & Ognibene F. 1989. CD4 counts as predictors of opportunistic pneumonias in human immunodefiency virus (HIV) infection. Ann. Intern. Med., 111:223-231.
13. Lidman, C., Berglund, O., Tynell, E. & Lindback, S. 1992. CD4 cells and CD4 percent as risk markers for Pneumocystis carinii pneumonia (PCP): implications for primary PCP prolilaxys. Scand. J. Infect. Dis., 24: 157-160.
14. Nevez, G., Raccurt, C., Vincent, P., Jounieaux, V. & Dei-Cas, E. 1999. Pulmonary colonization with Pneumocystis carinii in human immunodeficiency virus-negative patients: assessing risk with blood CD4+ T cell counts. Clin. Infect. Dis., 29:1331-1332.
15. Rice, W.R., Singleton, F.M., Link, M.J. & Walzer P.D. 1993. Regulation of surfactant phosphatidilcholine secretion from alveolar type II cells during Pneumocystis carinii pneumonia in the rat. J. Clin. Invest., 92:2778-2782.
16. Prevost, M.C., Escamilla, R., Aliouat, E.M., Cere, N., Coudert, P. & Dei-Cas, E. 1998. Pneumocystosis pathophysiology. FEMS Immunol. Med. Microbiol., 28:123-128.
17. Vassallo, R., Standing, JE. & Limper, AH. 2000. Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses. J. Immunol., 164:3755-3763.
18. Benfield, T.L., Lundgren, B., Shelhamer, J.H. & Lundgren, J.D. 1999. Pneumocystis carinii major surface glycoprolein induces interleukin-8 and monocyte chemoattractant protein-1 release from a human alveolar epithelial cell line. Eur. J. Clin. Invest., 29:717-722.
19. Renders, N., Verbrugh, H. & Van Belkum, A. 2001. Dynamics of bacterial colonization in the respiratory tract of patients with cystic fibrosis. Infect. Genet. Evol., 1:29-39.
20. Mc Manus, T.E., Moore, J.E., Crowe, M., Dunbar, K. & Elborn, J.S. 2003. A comparison of pulmonary exacerbations with single and multiple organisms in patients with cystic fibrosis and chronic Burkholderia cepacia infection. J. Infect., 46:56-59.